Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-023122
Filing Date
2021-03-25
Accepted
2021-03-25 21:10:11
Documents
2
Period of Report
2021-03-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3258
2 POA DOCUMENT poa.txt EX-24.3_975579 3116
  Complete submission text file 0001209191-21-023122.txt   7714
Mailing Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656
Business Address
Siffert Joao MD (Reporting) CIK: 0001534986 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40288 | Film No.: 21774322

Mailing Address 991C LOMAS SANTA FE #436 SOLANA BEACH CA 92121
Business Address 991C LOMAS SANTA FE #436 SOLANA BEACH CA 92121 858-293-4900
Design Therapeutics, Inc. (Issuer) CIK: 0001807120 (see all company filings)

EIN.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations